Diagnostics; making a difference


Parliamentary Links Day 2015

The science and technology community descended upon Portcullis House along with several MPs for Parliamentary Links Day 2015, hosted by the Society of Biology. BIVDA were there and give an overview of the day in this week's blog.

Read the rest of entry »

Cervical Cancer Week - Guest Blog from Jo's Trust

It’s Cervical Cancer Awareness week (15-21 June), and today guest blogger Robert Music, Chief Executive at Jo’s Cervical Cancer Trust, tells us about the importance of screening, and how we can potentially reduce the number of women diagnosed with cervical cancer from 1000s to only 100s in the not too distant future and eventually see the eradication of the disease.

Jo’s Cervical Cancer Trust is the only UK charity dedicated to women and their families affected by cervical cancer and cervical abnormalities. They offer information and support to patients and their families, while raising awareness about how cervical cancer can be prevented and campaign for best care and treatment. 


Read the rest of entry »

Testing the new Government - a diagnostics perspective on GE2015

As we enter the calm after the storm of an election period, it will be back to business for the newly elected Conservative majority Government.

Read the rest of entry »

Diagnosing cancer earlier saves lives

Cancer Research UK is the world’s largest cancer charity, raising awareness and funding research into the prevention, diagnosis and treatment of the disease. In this article, Matthew Wickenden, Early Diagnosis Manager at Cancer Research UK tells us about the importance of early diagnosis for cancer outcomes, what Cancer Research UK are doing in this field, and how the UK can improve its standing on the international stage.

Part of our Guest Blogs Series 

Read the rest of entry »

BIVDA Chief Exec addresses Parliamentary and Scientific Committee

Doris-Ann Williams MBE, CEO of BIVDA  presented to MPs at the latest meeting of the Parliamentary and Scientific Committee, which focused on life sciences in the UK. Welcomed to the meeting by Chair, Andrew Miller MP, Doris-Ann was joined by Professor Guy Poppy, Chief Scientific Adviser at the Food Standards Agency, and Dr Malcolm Skingle CBE, Director, Academic Liaison, GlaxoSmithKline.    With a wide range of parliamentarians, academics and industry members in the audience, Doris-Ann gave an introduction to diagnostics. She outlined where diagnostics are used and the importance that they play throughout the patient pathway; diagnosing (or ruling out diagnosis), monitoring, screening and predicting/preventing illness. She also gave case studies showing their necessity to healthcare, as well as examples of tests, and how they can combat the ‘grand challenges’ of the day, free up NHS resource and meet previously unmet clinical need.  “The upcoming years may well b ...

Read the rest of entry »

New NICE Guidance for Diabetes

NICE have issued two draft guidelines on diabetes care. Of the two documents, one focuses on adults with type 1 diabetes and the other concentrates on children and young adults, with either type 1 or type 2.  Sparking this call for updated guidance, the last was issued in 2004, is the worrying evidence that rates of diabetes diagnosis are swelling profusely throughout the country. Research shows that there are over 370,000 type 1 diabetes sufferers across the country, and 450 children with type 2.  The guidance for adults focuses on greater personalisation of care, and encourages a structured education program for diabetes sufferers to improve understanding. It also specifies achievable individualised targets for HbA1c levels and plasma glucose. The guidance supports testing at least 4 times a day on a routine basis for blood glucose and up to ten times if the patient fulfils any further conditions e.g. before and after sport, if they aren’t achieving HbA1c targets, during illness, pregn ...

Read the rest of entry »

Diagnostics; tackling the spread of AMR

Antimicrobial Resistance has been a hot topic in the news again this week, as two reports have been released reviewing the AMR situation as it stands. The first annual progress report following the Government’s five year strategy 2013-18 into AMR has been issued, available here.  The report sets out what work is underway and some important achievements in the first year of the Strategy including: • establishing baseline data to improve the way we monitor antibiotic prescribing and trends in resistance • publishing antimicrobial prescribing quality measures • launching an Antibiotic Guardian campaign (during European Antibiotic Awareness Day) • improving the coordination of research into AMR • leading the development of a new World Health Organisation (WHO) resolution on AMR • establishing an independent Review on AMR The Antibiotic Guardian Campaign took place on European Antibiotic Awareness Day, which BIVDA were able to also contribute. You can find ...

Read the rest of entry »

Increasing access to diagnostics hits the headlines again

Increasing access to diagnostics hits the headlines again Today (27 November, 2014) a commission established by the Lancet has reported that liver disease stands out as a glaring exception to the vast improvements made during the past 30 years in health and life expectancy for chronic disorders such as stroke, heart disease and many cancers. There are many striking things about this wide ranging and detailed report, but none more shocking than the fact that since the 1970s mortality rates from liver disease have increased 400 per cent, and in people younger than 65 years has risen by almost five-times.  To combat this increasing problem the commission, led by Prof Roger Williams, director of the Institute of Hepatology, calls for radical changes in the diagnosis of liver disease. Of particular interest, the report suggests that standard liver function tests provided in UK laboratories aren’t helping to detect early liver damage.  It also highlights that knowledge and awareness of liver dis ...

Read the rest of entry »

Meeting the AMR Challenge for European Antibiotics Awareness Day

Today is European Antibiotics Awareness Day 2014 (EAAD). This International Day of awareness was started in order to educate people about the appropriate use of antibiotics, in the fight against Antimicrobial Resistance (AMR).  AMR is one of the most serious challenges to our health that we face. The Chief Medical Officer, Dame Sally Davies has named it a “ticking time bomb” and the Government has ranked AMR on the list of threats to the UK, on a par with terrorism and major natural disasters, like flooding (see article). As resistance to antibiotics looms, the Chief Medical Officer has warned that today’s routine operations could become deadly in just 20 years if we lose the ability to fight infection. Across Europe, organisations and charities, clinicians and patients will be taking part in activities to spread the message – that the threats to antibiotics are severe, and we all must work together to reduce inappropriate prescribing. At BIVDA we will be taking part in Europea ...

Read the rest of entry »

Party Conference Season 2014

With the 2015 General Election fast approaching, BIVDA co-hosted three discussion meetings at the Labour, Conservative and Liberal Democrat Party conferences.  As part of Life Science UK, and linking with the Association of Medical Research Charities, BIVDA welcomed a wide range of stakeholders to the meetings. Key issues were raised, including the adoption of vital technologies and innovations, and the value diagnostics can bring to the patient pathway.  Across the three meetings it was recognised that effectively and appropriately harnessing the wealth of data the NHS could potentially provide was fundamental to the future of research, reducing variation and ultimately optimisation of treatment and care for patients. In Manchester, Jamie Reed MP, Shadow Minister for Health, welcomed advancements in technology and heightened collaboration between healthcare partners and the NHS. A central tenet to his view was that while patients must be assured that their personal data is being used appropriatel ...

Read the rest of entry »

Pages: Previous1234567NextReturn Top